SECsense Logo

Amgen Inc. 8-K Report: Key Insights on Debt and Stock Information

$AMGN
Form 8-K
Filed on: 2025-05-01
Source
Amgen Inc. 8-K Report: Key Insights on Debt and Stock Information

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: Amgen Inc.
  • CIK Code: 0000318154
  • Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799
  • Phone Number: 805-447-1000
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: May 1, 2025
  • SEC File Number: 001-37702
  • EIN: 95-3540776
  1. Stock Information:
  • Common Stock Par Value: $0.0001
  • Stock Exchange: NASDAQ
  • Common Stock Identifier: AMGN
  • 2.000% Senior Notes due 2026 Identifier: AMGN26
  • Stock Class: Common Stock
  • Segment Information: The filing includes details on common stock and senior notes, indicating a structured approach to financial reporting.
  1. Debt Information:
  • Type of Debt: 2.000% Senior Notes
  • Maturity: Due in 2026
  1. Reporting Context:
  • The context identifiers indicate that the report pertains to specific classes of stock and their corresponding financial metrics as of May 1, 2025.

Insights:

  • Debt Management: The issuance of 2.000% Senior Notes due 2026 suggests Amgen is actively managing its debt portfolio, potentially to finance operations or investments at a relatively low interest rate.
  • Market Positioning: Being listed on NASDAQ, Amgen maintains visibility in the equity markets, which is crucial for investor relations and capital raising.
  • Current Reporting Date: The report's specific date indicates a timely disclosure of financial information, which is essential for compliance and investor transparency.

Overall, the report highlights Amgen's financial instruments (common stock and senior notes) and compliance with SEC regulations, which are critical for stakeholders monitoring the company’s financial health and market positioning.